Par Drugs & Chemical Quarterly Results for Trading Insights
PAR • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹13 Cr
QMarch 2025
Par Drugs & Chemical Quarterly Results Key Highlights
- Revenue of ₹103 Cr in March 2025 (+0.0% vs March 2025, +7.3% vs March 2024)
- Net Profit of ₹13 Cr in March 2025 (+0.0% vs March 2025, -13.3% vs March 2024)
- EBITDA of ₹22 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 19.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹10.86 in March 2025 (+0.0% vs March 2025)
Par Drugs & Chemical Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 102 | 103 | 96 | 96 | 75 | -1.0% | - |
| Net Profit (₹ Cr) | 10 | 13 | 15 | 11 | 9 | - | - |
| EBITDA (₹ Cr) | 17 | 22 | 23 | 18 | 16 | - | - |
| EPS (₹) | 7.90 | 10.86 | 11.78 | 9.21 | 7.49 | - | - |
| Operating Margin (%) | 13.0% | 19.0% | 24.0% | 19.0% | 22.0% | - | - |
Par Drugs & Chemical Share Price Trend Around Quarterly Results
Visualize Par Drugs & Chemical's 1-year price movement across quarterly results — ideal for logging trades in Par Drugs & Chemical share price
chart using Tickjournal. All values in ₹.
Related Pages for Par Drugs & Chemical
Additional stock information and data for PAR
Revenue Trend (₹ Cr)
March 2023
96
March 2024
96
March 2025
103
2026
102
Net Profit Trend (₹ Cr)
March 2023
11
March 2024
15
March 2025
13
2026
10
Operating Margin Trend (%)
March 2023
19.0%
March 2024
24.0%
March 2025
19.0%
2026
13.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Par Drugs & Chemical quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores